Oesophageal cancer

• Health & Medicine

Why consistent and funded cancer policies are key to improving cancer survival

Research from the International Cancer Benchmarking Partnership has found a link between cancer policy consistency over time and survival for six cancer types Research from the International Cancer Benchmarking Partnership has found a link between cancer policy consistency over time and survival for six cancer types

1 November 2022

• Health & Medicine
• Science & Technology

How erectile dysfunction drugs could be the key to overcoming treatment resistance in oesophageal cancer

Researchers have found a drug that targets the tumour microenvironment that could improve treatment for certain cancers. But it might not be the kind of drug you expect.  Researchers have found a drug that targets the tumour microenvironment that could improve treatment for certain cancers. But it might not be the kind of drug you expect. 

21 June 2022

• Science & Technology

Unravelling the mystery of Barrett’s oesophagus

Barrett’s oesophagus affects around 1 in every 100 to 200 people in the UK, and, for a small number of people, can develop into oesophageal cancer. But the origins of the condition have remained a mystery for decades, until now. Barrett’s oesophagus affects around 1 in every 100 to 200 people in the UK, and, for a small number of people, can develop into oesophageal cancer. But the origins of the condition have remained a mystery for decades, until now.

25 October 2021

• Health & Medicine

Immunotherapy approved for some people with oesophageal cancer on NHS in England

The immunotherapy drug nivolumab (Opdivo) has been made available for some people in England with oesophageal cancer, in what has been described as a ‘step change’ for people with this cancer. The immunotherapy drug nivolumab (Opdivo) has been made available for some people in England with oesophageal cancer, in what has been described as a ‘step change’ for people with this cancer.

20 October 2021

• Health & Medicine

New option to treat advanced oesophageal cancer approved for NHS in Scotland

The Scottish Medicines Consortium (SMC) has approved the immunotherapy drug nivolumab (Opdivo) for some patients with advanced oesophageal cancer. The Scottish Medicines Consortium (SMC) has approved the immunotherapy drug nivolumab (Opdivo) for some patients with advanced oesophageal cancer.

11 August 2021

• Science & Technology

Zooming in: Fine-tuning the picture to diagnose oesophageal cancer earlier 

Our researchers have developed specialised cameras to detect cancer cells that can be hard for both surgical cameras and the naked eye to spot. Our researchers have developed specialised cameras to detect cancer cells that can be hard for both surgical cameras and the naked eye to spot.

11 August 2021

• Health & Medicine
• Science & Technology

Cytosponge-AI combo could help doctors diagnose Barrett’s oesophagus

Cancer Research UK-funded researchers have developed a tool to help experts diagnose a condition that can increase the risk of developing oesophageal cancer. Cancer Research UK-funded researchers have developed a tool to help experts diagnose a condition that can increase the risk of developing oesophageal cancer.

15 April 2021

• Science & Technology

Cytosponge: A ‘sponge on a string' test to detect oesophageal cancer earlier

Looking at the latest results from the BEST3 trial, analysing the ‘sponge-on-a-string' test to detect oesophageal cancer earlier. Looking at the latest results from the BEST3 trial, analysing the ‘sponge-on-a-string' test to detect oesophageal cancer earlier.

31 July 2020

• Health & Medicine

Immunotherapy comparable to chemo for some advanced stomach cancers

An immunotherapy drug could prove just as effective as chemotherapy in prolonging the lives of patients with advanced cancers of the stomach or food pipe. An immunotherapy drug could prove just as effective as chemotherapy in prolonging the lives of patients with advanced cancers of the stomach or food pipe.

1 June 2019

• Health & Medicine
• Science & Technology

Clearing up chemo options for frail and elderly patients with advanced oesophageal and stomach cancers

Older patients with advanced oesophageal and stomach cancers might benefit from low dose treatment, according to our unpublished clinical trial results. Older patients with advanced oesophageal and stomach cancers might benefit from low dose treatment, according to our unpublished clinical trial results.

15 May 2019

• Science & Technology

Inflammation and cancer: unravelling a 150-year-old mystery

Inflammation can prevent infections and helps repair injuries. But for people with long-term inflammatory conditions, it can sometimes lead to cancer. Inflammation can prevent infections and helps repair injuries. But for people with long-term inflammatory conditions, it can sometimes lead to cancer.

28 March 2019

• Health & Medicine

Headlines saying ‘hot tea causes oesophageal cancer’ miss crucial details

Hot drinks have hit headlines today, with new research sparking claims that hot tea ‘doubles the risk of oesophageal cancer’. But how hot is hot? And are the headlines anything to worry about? Hot drinks have hit headlines today, with new research sparking claims that hot tea ‘doubles the risk of oesophageal cancer’. But how hot is hot? And are the headlines anything to worry about?

20 March 2019